Genmab scores a ‘hat trick’ with positive data for its experimental cancer drug, petosemtamab, Jefferies says.

F5 Stock Is Having Its Worst Day in Over a Decade. Blame Its Costly AI Push.

I agree to the Terms of Use , Privacy Notice and Cookie Notice.

Trian Fund Management has submitted an all-cash offer to acquire Wendy’s in a deal that could take the fast-food chain ...

Julie Sweet snapped up 12,200 shares of the large consulting company at an average price of about $246. The stock’s June 30 ...

Boeing CEO Kelly Ortberg Gets Strike One. What the Stock Needs Now. A cardinal Wall Street sin is missing financial guidance.

Warsh looks to be getting a head start on shrinking the Fed's balance sheet. The chairman has been advocating for a smaller ...

Wingstop shares rose sharply Wednesday as the chicken-wing chain teased ambitious expansion plans in India, giving investors ...

The VIX shows complacency. Other gauges don’t. No matter what happens this week, markets are likely to see big swings.

Enphase Stock Sinks. It Will Have to Grow Its Way Out of a Bleak Residential Solar Market. Wall Street was extremely ...

Biogen is leaning on newer drugs, including recently acquired assets, as its multiple sclerosis franchise faces ongoing ...